Member Info for substp

"Next 12months s/p is projected to be 5--6p by brokers.this means no good news at all next 12 months." Brokers forecasts : Show us please . Ebiox : US EPA approvals possibly by the end of 2006 with state approvals to follow 2/3 months later . Optiscope : "The Group has engaged Burnham Securities, Inc, an US investment bank to assist in monetising its investment in Optiscope and an information memorandum is being sent to interested parties." "Gordon Wood has resigned as an executive director with immediate effect, to pursue other opportunities. He will remain as a consultant to the Group for a short period to assist in the commercialisation of the Optiscope business. " http://www.optiscopetech.com/aboutus.html October 2006 Development is proceeding as planned

"HSS management has made significant reductions in overheads, capital expenditure and reduced working capital requirements. 'On time and in full' delivery figures have seen a significant improvement and the HSS management team has recently been strengthened with the appointment of Adrian Hughes as sales and marketing director, with excellent experience in the sector. In addition, sales of the Ebiox products are being handled through the Warrington operation." During the period HSS also secured supplier arrangements in the Far East, although the funding required to finance overseas orders has resulted in a requirement for additional working capital." "With new management in place at HSS and trading at a near breakeven position, the Board remains optimistic about the prospects for the Group. It is focused, not only on achieving a resumption of profitability, but in exploring all alternatives to realise value for shareholders." New management , cost cutting , and cheaper products from Thailand and China . This is why HSS is going to be alright .

Would everyone please post where exactly they got their info. from . ""we will start making a small profit first half" 27.Jul.2006 AGM Statement They said :"“As expected HSS has over the last two months returned to operating profitability. The Board anticipates that this business will record a small loss for the first half of the financial year after the lower seasonal sales during the summer. " 2 November 2006 Healthcare Enterprise Group plc Interim results, proposed £2.0m cash placing and board change They have now followed it up with : " The Group reported a loss before tax and exceptional items of £0.95m (2005: loss £2.1m). This was achieved following significant cuts in overheads as costs were reduced to £4.0m (2005: £5.7m)." "The net loss for the period was £0.1m (2005: loss £2.3m)." "The Board expects to continue to record a loss for the second half of the year at the operating level, although it is anticipated that this will be lower than the first half loss as the benefits of cost reductions and improved margins are experienced." "HSS management has made significant reductions in overheads, capital expenditure and reduced working capital requirements. 'On time and in full' delivery figures have seen a significant improvement and the HSS management team has recently been strengthened with the appointment of Adrian Hughes as sales and m

Servier prides itself on the design and quality of its buildings around the world, as is evidenced by the Arklow plant, and with a company the calibre of Servier as Belview’s flagship occupant, further high-value investment will undoubtedly follow." "Servier’s manufacturing facility in Arklow is thriving and this expansion is a strong indicator of the company’s success here to date. http://test.accountancyireland.ie/dsp_news.cfm?id=25

Arklow and the Belview industrial estate on the Waterford / Kilkenny border are above and on the North / Northeast side of Waterford County. Cork of Cork County is West/Southwest of Waterford County . They are not in the same area .

A new , very small , but significant statement ! October 2006 "Development is proceeding as planned " http://www.optiscopetech.com/aboutus.html

"The British Dental Journal | Volume 201 | Issue 8 |21 October 2006" http://www.nature.com/bdj/journal/v201/n8/full/4814202a.html

"We have also agreed another long term major supply agreement with Ngamdee Cotton, a Thai cotton processor, which will supply a large proportion of HSS's cotton products." We have been here before : http://www.ngamdeecotton.com/index.htm http://data1.ccn.mofcom.gov.cn/pls/wdat/b_query_en.b_detail_company_en?p_corpid=816067

The Interim will be up through the end of Aug. . We’ve already been warned of a loss . Many things weren’t to happen until the end of this year anyway . We have seen many examples of HCEG putting their “ Ducks in a Row “ . The forward statement in the Interim as well as any other RNSs this year will be what’s important . Not how badly (which we already know ) they have done in the past . As a shareholder I have no reason to believe this company would fold tomorrow and from what we have seen lately they are striving to put things right . Have the management learnt their lesson ? From what I can see , YES ! Do I feel negative or anxious ? Sometimes . But when I look as these facts and knowing we will be getting news in the near future ....

The positives : £2 million financing facility secured . HSS was in profit 2 months before the last annual statement . New contracts with Ngamdee Cotton and Sunmed USA for cheaper supplies . Deferred payments for Crest out of the way. CICS was in profit anyway . We’ve seen several people go . House cleaning . Burnham Securities the New York Investment Bank handling Optiscope with Jenoptik wanting to invest in the lines to produce the product . Ebiox waiting for the US EPA approval at the end of this year with it already been filed with the State of California . We’ve seen them on the net in China (Guangzhou New Mutual Ben Development Co. Ltd ) , Germany (Medizel) and with Kawasumi in Japan . There’s Ridgecrest ( MDS plus many other start ups ) that is of value to HCEG . We also have Fertiligent , Medilator , Ultrasurge , and Deliverance that are ongoing because they are individual companies with other investors other than HCEG involved . Of late , other than Mr. Bruck , we haven’t seen any large scale dumping of any kind . In fact , I would venture to say that all of those shares from Mr. Bruck and some of the ex employees looked to have already been taken up . The Interim will be up through the end of Aug. . We’ve already been warned of a loss . Many things weren’t to happen until the end of this year anyway . We have seen many examples of HCEG putting their “ Ducks in a Row “ . The forwar

Ridgecrest further seeks to acquire and operate healthcare management companies and leverage its relationships and strategic and financial expertise to enhance and grow these enterprises. For more information on Ridgecrest Healthcare Group, Inc., please visit our website at: www.rchealthcare.com

He also predicted consolidation in the industry with new opportunities for hospitals to acquire imaging centers from physician owners because of federal reimbursement changes. George Goodwin, Vice President for Symbion Healthcare, also presented similar expectations for the continued growth and profitability of ambulatory surgery centers and predicted that hospitals would increasingly have to partner with physicians in joint ventures in order to maintain or grow their market share. Phil Dalton, CEO of Ridgecrest Healthcare Group, emphasized that while hospitals have lost market share in the growing ambulatory services market and because inpatient profitability was stagnant or shrinking, they would need to develop an ambulatory service focus to maintain, recapture and grow overall profitability. According to Mr. Dalton, "All too frequently, hospitals have been the breeding ground for new medical service innovations only to lose their foothold in a growth market to more nimble and entrepreneurial players once the service proves profitable. Without a significant commitment to the development and funding of an ambulatory services plan, hospitals will continue to lose out on the most profitable service opportunities in healthcare." Ridgecrest Healthcare Group, Inc. is a healthcare management services company that works with large healthcare providers, healthcare companies, government and related companies and organizations. Ridgecrest further seeks to acquir

From another person and board : Ridgecrest Healthcare Group Announces Successful Inaugural National Conference EL SEGUNDO, CA -- (MARKET WIRE) -- October 19, 2006 -- MDS Conference Services, a division of Ridgecrest Healthcare Group, Inc., (PINKSHEETS: RGHG), held its first national healthcare conference entitled "Strategies for Success in the Hot Ambulatory Services Market" at the Wynn Las Vegas, October 12-13, 2006. The event, attended by hospital executives, industry experts and leaders of companies serving the healthcare industry, was well attended and offered expert insight on the highly competitive ambulatory services marketplace. In discussing the conference's success and attendees' and presenters' positive reaction to the conference, Stuart Bruck, Executive Chairman of Ridgecrest Healthcare Group, stated, "This, our first conference for MDS Conference Services, more than met our expectations. We look forward to offering multiple conferences on timely healthcare issues over the coming years." A number of industry executives and experts presented at the conference including Paul Viviano, Chairman and CEO of Alliance Imaging, the world's largest provider of high tech medical imaging services. Mr. Viviano reviewed trends for continued double-digit percentage growth in healthcare imaging services because of the aging of the population and increasing use of CT, MRI and PET for medical diagnostics. He also predicted consolidation in the indus

Ridgecrest Healthcare Group, Inc. "HCEG owns 17.3% of RCHG in the form of common stock and in addition the equivalent of 31.4% of the company in non voting preference stock." http://rchealthcare.com/ Not too sure about this situation though ??? "Since year end, in order to provide an incentive for the managers of Ridgecrest which would more accurately align their interests with the company’s shareholders, HCEG agreed to grant a five year option over the preference shares at an exercise price of US$800,000 plus profit share on sale." A large part already sold off if it does well ? 31.4 % of the company for @ £420,000.00 http://www.hcegroup.com/download/3480/Annual%20Report%202006.pdf

"and Warrington alone may well be worth £13m by now" So why has the HCEG Market Capitalisation been shoved down to just over £6m ? Add Ebiox all of the other projects .... ? The S.P. isn't about the company value but what certain organisations can squeese out of it with a bit of help from the punters . http://www.michaelwalters.com/stories/news.phtml?num=2752

On 26th July 2006 the Company entered into an Exclusive Distribution Agreement between Ngamdee Cotton Company Limited, Healthcare Sales & Service Limited and Sunmead USA (“the Agreement”). http://www.hcegroup.com/presscentre/newsdetail.jsp?newsitemdisplay_id=3494 Let's not forget , Sunmed USA has moved in with HCEG California : http://kepler.ss.ca.gov/corpdata/ShowLpllcAllList?QueryLpllcNumber=200618010057

About CFH CFH GmbH has been Sachsen LB's investment company since 1996. With eleven professionals, CFH deals with a funding volume of just under 200 million euro provided by Sachsen LB as well as outside investors. CFH works in several regions and has now accompanied more than 70 small- and medium-sized firms with the provision of expansion financing, follow-up solutions etc. People David Dolev-Lipitz, Capital Point CEO Limor Dahan, Capital Point CFO Dr. Shuki Gleitmann, Capital Point Supervisory Board Hava Shechter, Consultant Christian Vogel, CFH GmbH Managing Director Harald Rehberg, CFH GmbH "Prokurist" (authorised signatory) Consultants Financial: PricewaterhouseCoopers, Tel Aviv Legal: Nira Lahav, Lahav, Litvak, Abadi & Co., Tel Aviv, Israel Jörg Windt, SJBerwin, Frankfurt am Main, Germany http://www.cfh.de/EN/Informations/News/2006/20060615.html

Capital Point is a shareholder of Optiscope that was floated on the Tel Aviv Stock Exchange . http://www.meytag.org/asp/portfolio_company.asp?id=105 ...................................................................... CFH is part of the Sachsen LB Gruppe in Germany : http://www.sachsenlb.de/DE/SachsenLB/SlbGroup/index.html ....................................................................... The two incubators mentioned are Meytag High Tech Venture and OHV (Ofakim Hi-tech Ventures)............... CFH takes Capital Point to the Israeli stock exchange The CFH brought its Israeli technological holding Capital Point to Tel Aviv Stock Exchange at the start of June. The issue for the company, which serves as a holding for two incubators in Israel, was plainly over-subscribed. The young company achieved a market capitalisation of more than USD 25 m. CFH has accompanied Capital Point since it was founded in the year 2000. In the run-up to the IPO, two financing rounds in December 2005 and April 2006 brought in more than USD 10 m; among others, SFKT also participated. About Capital Point Capital Point is a joint venture by various groups of investors to finance Israeli technology companies. Capital Point has especially pioneered the privatisation of the Israeli incubator programme, today running two incubators in Qatzrin and Ofaqim. This means that Capital Point has a holding in more than 40 technology companies. About CFH CFH GmbH has been Sachsen LB

Yes , I believe they deal direct with their ultra products ( Instrument cleaners )

"Jenoptik Polymer Systems GmbH, has confirmed that it will invest directly in the equipment and components required for mass production of the initial Optiscope product." http://www.hcegroup.com/presscentre/newsdetail.jsp?newsitemdisplay_id=3482 "Our U.S. office is located in Rochester, New York via a strategic alliance with Apollo Optical Systems and RPC Photonics, Inc." "This alliance, which was announced in March 2006, enables the three firms to combine competencies in the manufacture of polymer-based optical products and light-shaping, micro-structured components for the medical, defense, automotive, and commercial markets. JENOPTIK Polymer Systems, Inc offers North American customers the same complete process chain capabilities that JENOPTIK Polymer Systems GmbH offers to the European market. The process chain includes everything from optical design to opto-electronic assembly and packaging. The customers benefit from shorter lead time of a product launch and an improved quality control." http://www.jenoptik.com/cps/rde/xchg/SID-26EE34DB-8B9C10F4/jenoptik-ps/hs.xsl/3927.htm